Mydecine Innovations Group Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was CAD 20.95 million compared to CAD 9.25 million a year ago. Basic loss per share was CAD 0.68 compared to CAD 1.07 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0123 USD | -20.62% |
|
+23.00% | -17.45% |
1st Jan change | Capi. | |
---|---|---|
-17.45% | 758K | |
+16.59% | 44.44B | |
+42.44% | 40.03B | |
-10.62% | 37.68B | |
+29.92% | 31.46B | |
-9.23% | 27.29B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |
- Stock Market
- Equities
- MYCOF Stock
- News Mydecine Innovations Group Inc.
- Mydecine Innovations Group Inc. Reports Earnings Results for the Full Year Ended December 31, 2023